Sisram Medical is a global consumer wellness group that specializes in harnessing natural energy sources for the treatment of aesthetics and medical clinical indications, self-described as deeply rooted in the global medical aesthetics industry for over two decades.

Sisram Medical

Sisram Medical | 1,823 followers on LinkedIn. Sisram Medical Ltd (1696.HK), the first Israeli company listed on the Hong Kong Stock Exchange Main Board, was established in 2013 for the acquisition of Alma, a leading provider of energy-based surgical and medical aesthetics devices, one of the top global leaders in its industry. Sisram Medical is majority held by Fosun Pharma, a leading healthcare group in the people&#39;s republic of China. Sisram is active across over 90 countries worldwide with 9 subsidiaries.

CEO at Sisram Medical & Alma | FOSUN Global Partner

Lior Dayan

Medical Device Quality & Regulatory

Hirshnzon Avi

Chief Operations Officer at Sisram Medical

Ran Ezioni

Deputy Regional CEO, North America, Sisram Medical Ltd

Annie Belsham

“In the rapidly evolving medical aesthetic industry, Sisram has achieved an all-time high in new orders, reflecting strong customer confidence in Alma’s core platforms. This milestone, driven by the rapid and better-than-expected market adoption of Alma’s recent launches, showcases our commitment to delivering high-value offerings to our partners and increasing patient lifetime value to support clinic growth,” says Sisram and Alma CEO, Lior Dayan . Sisram Medical announces First-Half 2024 performance>> https://bit.ly/4eaBSEy

Sisram Medical announces First-Half 2024 performance, with the EBD segment maintaining steady growth and direct sales reaching a new all-time high. #medicalaesthetics #wellness #ecosystem #sisrammedical

Sisram Medical announces 2023 annual revenue results of US$359.3M, marking all-time record high for the direct sales portion #medicalaesthetics #wellness #ecosystem #sisrammedical

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Euro

Google Tag Manager

Apple Mobile Web Clips Icon

Google Font API

Google Analytics

Content Delivery Network

Business Management

Tsur Genosar

Marketing and Product

Fiona Zhang

Li Chun

Ziv Karni

Co-founder

Ronen Lazarovich

Jianping Hua

Middle East and North Africa (MENA) Public Companies With More Than 10 Employees

Middle East and North Africa (MENA) Public Companies With More Than 500 Employees

Europe, Middle East, and Africa (EMEA) Hospital Companies

Medical Device Public Companies With Fewer Than 1000 Employees

Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical and minimally invasive treatment systems worldwide. 

It offers a portfolio of treatment systems for non-invasive medical aesthetic treatments, including hair removal, skin rejuvenation, skin resurfacing, vascular and pigmented lesions treatment, tattoo removal, acne treatment, cellulite reduction, body contouring, and skin tightening; and minimally invasive treatments, such as vaginal rejuvenation, laser-based liposuction, treatment of varicose veins, and treatment of hyperhidrosis. 

The company sells its products directly to treatment providers, such as plastic surgeons and dermatologists, primary care physicians, obstetricians, gynecologists, and aestheticians, as well as ear, nose, and throat specialists; to distributors. Sisram Medical Ltd offers its products under the Alma, Soprano, Harmony, Accent, and FemiLift brands.

Caesarea

Hefa

Israel

Asia

Sisram Medical Ltd

Sirsram Medical announces NMPA approval for DAXXIFY®

/C O R R E C T I O N — Sisram Medical Ltd/

Alma, a Sisram Medical company, is establishing a direct operation in China after completing the acquisition of PhotonMed

Sisram Medical Ltd Announces 2021 Record Annual Results

Alma Celebrates Its Platinum Anniversary - 20 Years of Global Leadership

Sisram Med Presents its Best Annual Reports to Date

Top 10 Middle Eastern IPOs of 2017

The New ALMA BEAUTY SPADEEP Platform Launched Globally After Receiving Outstanding Feedbacks in the Japanese Market

Monday, 27 November 2017, 11:38 HKT/SGT

Sisram Medical Ltd Increase in Shareholding by Controlling Shareholder and CEO As a Vote of Confidence and Trust in the Company's Future Success

Alma provides energy-based solutions for surgical, medical aesthetics, and beauty markets, offering technologies for various treatments including skin rejuvenation, body contouring, and acne treatment.

Sisram Medical offers injectables for skin treatment, including dermal fillers and skin boosters, focusing on anti-aging and aesthetic enhancements.

Copulla is a digital dentistry service that streamlines the dental workflow from intra-oral scanning to the delivery of dental appliances, enhancing efficiency and precision in aesthetic dentistry.

LMNT is a personal care brand that integrates wellness into daily routines, focusing on skin care and self-care products.

India

Hong Kong

Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio, including hair removal, skin rejuvenation, acne and acne scars, body and face contouring, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodelling injectables, personal care, aesthetic dentistry, trans epidermal delivery, cellulite treatment, stretch marks, vascular and pigmented lesions, hydradermabrasion, blepharoplasty-non surgical eyelid lift, liposuction, feminine health, and sexual rehabilitation. The company manufactures, distributes, and sells medical equipment. It offers its products under the Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT brands. Sisram Medical Ltd was incorporated in 2013 and is headquartered in Caesarea, Israel.

news impact assignment basic	general
public peers	general	Nov 17, 2024 11:52 PM	0176d4f5
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 17, 2024 11:52 PM	cace52d1
crunchbase trigger	general	Nov 17, 2024 11:52 PM	ddcf258a
crunchbase profile	general	Nov 18, 2024 11:05 AM	6c434d00
li profile	general	Nov 17, 2024 11:52 PM	852b0b43
translate crunchbase fundingrounds	general	Nov 18, 2024 11:26 AM	5f721cc6
peers	general	Nov 17, 2024 11:52 PM	17a9763c
news basic	general	Nov 17, 2024 11:52 PM	d86dabdd
bundesanzeiger	filings
financials download nd	financials
private financials	financials

1696

COM:SISRAM-MEDICAL

Sisram Medical

Last Close

3.39

14/02 07:58

Market Cap

1.55B

Beta: -

Volume Today

1.45M

Avg: -